Comparative Proteomic Analysis of Type 2 Diabetic versus Non-Diabetic Vitreous Fluids
Life · 16.07.2024 · 14 (7) · 883
DOI: 10.3390/life14070883 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life, online erschienen am 16.07.2024. Verfasst von Abdulaziz H Alanazi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Clinical and Experimental Therapeutics, University of Georgia, Augusta, GA 30912, USA. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NEI NIH HHS, NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
Background
Diabetic retinopathy (DR) is a leading cause of vision loss, with complex mechanisms. The study aimed to comprehensively explore vitreous humor of diabetic and non-diabetic individuals, paving the way for identifying the potential molecular mechanisms underlying DR.
Methods
Vitreous samples from type 2 diabetic and non-diabetic subjects, collected post-mortem, were analyzed using liquid chromatography–mass spectrometry. Pathway enrichment and gene ontology analyses were conducted to identify dysregulated pathways and characterize protein functions.
Results
Pathway analysis revealed dysregulation in multiple metabolic and signaling pathways associated with diabetes, including glycerolipid metabolism, histidine metabolism, and Wnt signaling. Gene ontology analysis identified proteins involved in inflammation, immune response dysregulation, and calcium signaling. Notably, proteins such as Inositol 1,4,5-trisphosphate receptor type 2 (ITPR2), Calcium homeostasis endoplasmic reticulum protein (CHERP), and Coronin-1A (CORO1A) were markedly upregulated in diabetic vitreous, implicating aberrant calcium signaling, inflammatory responses, and cytoskeletal reorganization in DR.
Conclusions
Our study provides valuable insights into the intricate mechanisms underlying DR and highlights the significance of inflammation, immune dysregulation, and metabolic disturbances in disease progression. Identification of specific proteins as potential biomarkers underscores the multifactorial nature of DR. Future research in this area is vital for advancing therapeutic interventions and translating findings into clinical practice.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical and Experimental Therapeutics, University of Georgia, Augusta, GA 30912, USA.
- Vision Discovery Institute, Augusta University, Augusta, GA 30912, USA.
- Department of Clinical Practice, College of Pharmacy, Northern Border University, Rafha 91531, Saudi Arabia.
ORCID-Profile: Shengshuai Shan, S Priya Narayanan, Payaningal R Somanath
Förderung
- NEI NIH HHS
- NIH HHS
- NCATS NIH HHS
- National Institutes of Health
- National Center for Advancing Translational Sciences (NCATS)
Zitieren
APA
Alanazi, A. H., Shan, S., Narayanan, S. P., & Somanath, P. R. (2024). Comparative Proteomic Analysis of Type 2 Diabetic versus Non-Diabetic Vitreous Fluids. Life, 14(7), 883. https://doi.org/10.3390/life14070883
Vancouver
Alanazi AH, Shan S, Narayanan SP, Somanath PR. Comparative Proteomic Analysis of Type 2 Diabetic versus Non-Diabetic Vitreous Fluids. Life. 2024;14(7):883. doi:10.3390/life14070883
BibTeX
@article{Alanazi2024,
author = {Alanazi, Abdulaziz H and Shan, Shengshuai and Narayanan, S Priya and Somanath, Payaningal R},
title = {Comparative Proteomic Analysis of Type 2 Diabetic versus Non-Diabetic Vitreous Fluids},
journal = {Life},
year = {2024},
volume = {14},
number = {7},
pages = {883},
doi = {10.3390/life14070883}
}
EUVIMED